JP2013540755A5 - - Google Patents

Download PDF

Info

Publication number
JP2013540755A5
JP2013540755A5 JP2013530234A JP2013530234A JP2013540755A5 JP 2013540755 A5 JP2013540755 A5 JP 2013540755A5 JP 2013530234 A JP2013530234 A JP 2013530234A JP 2013530234 A JP2013530234 A JP 2013530234A JP 2013540755 A5 JP2013540755 A5 JP 2013540755A5
Authority
JP
Japan
Prior art keywords
alkyl
group
alkoxy
substituted
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013530234A
Other languages
English (en)
Japanese (ja)
Other versions
JP5855109B2 (ja
JP2013540755A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/052399 external-priority patent/WO2012040230A1/en
Publication of JP2013540755A publication Critical patent/JP2013540755A/ja
Publication of JP2013540755A5 publication Critical patent/JP2013540755A5/ja
Application granted granted Critical
Publication of JP5855109B2 publication Critical patent/JP5855109B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013530234A 2010-09-20 2011-09-20 イミダゾトリアジノン化合物 Expired - Fee Related JP5855109B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38469410P 2010-09-20 2010-09-20
US61/384,694 2010-09-20
PCT/US2011/052399 WO2012040230A1 (en) 2010-09-20 2011-09-20 Imidazotriazinone compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015239514A Division JP2016104747A (ja) 2010-09-20 2015-12-08 イミダゾトリアジノン化合物

Publications (3)

Publication Number Publication Date
JP2013540755A JP2013540755A (ja) 2013-11-07
JP2013540755A5 true JP2013540755A5 (US20040106767A1-20040603-C00005.png) 2014-11-13
JP5855109B2 JP5855109B2 (ja) 2016-02-09

Family

ID=44720178

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013530234A Expired - Fee Related JP5855109B2 (ja) 2010-09-20 2011-09-20 イミダゾトリアジノン化合物
JP2015239514A Pending JP2016104747A (ja) 2010-09-20 2015-12-08 イミダゾトリアジノン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015239514A Pending JP2016104747A (ja) 2010-09-20 2015-12-08 イミダゾトリアジノン化合物

Country Status (17)

Country Link
US (3) US20120157458A1 (US20040106767A1-20040603-C00005.png)
EP (2) EP3181566A1 (US20040106767A1-20040603-C00005.png)
JP (2) JP5855109B2 (US20040106767A1-20040603-C00005.png)
CN (1) CN103313988B (US20040106767A1-20040603-C00005.png)
AR (1) AR083058A1 (US20040106767A1-20040603-C00005.png)
AU (2) AU2011305568B2 (US20040106767A1-20040603-C00005.png)
BR (1) BR112013008140A8 (US20040106767A1-20040603-C00005.png)
CA (1) CA2811714C (US20040106767A1-20040603-C00005.png)
DK (1) DK2619208T3 (US20040106767A1-20040603-C00005.png)
ES (1) ES2610360T3 (US20040106767A1-20040603-C00005.png)
HK (1) HK1187908A1 (US20040106767A1-20040603-C00005.png)
MX (1) MX2013003093A (US20040106767A1-20040603-C00005.png)
PL (1) PL2619208T3 (US20040106767A1-20040603-C00005.png)
RU (1) RU2603140C2 (US20040106767A1-20040603-C00005.png)
TW (1) TWI541244B (US20040106767A1-20040603-C00005.png)
UY (1) UY33616A (US20040106767A1-20040603-C00005.png)
WO (1) WO2012040230A1 (US20040106767A1-20040603-C00005.png)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103313988B (zh) 2010-09-20 2016-06-08 论坛医药有限公司 咪唑并三嗪酮化合物
CN106905324B (zh) 2011-10-10 2018-09-25 H.隆德贝克有限公司 具有咪唑并吡嗪酮骨架的pde9抑制剂
SG11201403909RA (en) 2012-01-26 2014-10-30 Lundbeck & Co As H Pde9 inhibitors with imidazo triazinone backbone
WO2013142269A1 (en) * 2012-03-19 2013-09-26 Envivo Pharmaceuticals, Inc. Imidazotriazinone compounds
WO2014024125A1 (en) 2012-08-08 2014-02-13 Celon Pharma S.A. Pyrazolo[4,3-d]pyrimidin-7(6h)-one derivatives as pde9 inhibitors
CN102786525B (zh) 2012-08-08 2014-12-17 中山大学 N-取代吡唑并[3,4-d]嘧啶酮类化合物、其制备方法及其应用
BR112015009751A2 (pt) 2012-10-31 2017-07-11 Bayer Cropscience Ag novos compostos heterocíclicos como pesticidas
TW201629064A (zh) 2014-10-10 2016-08-16 H 朗德貝克公司 作爲pde1抑制劑之三唑並吡酮
US20180044343A1 (en) * 2015-03-16 2018-02-15 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic imidazolo derivative
TW201643167A (zh) * 2015-04-22 2016-12-16 H 朗德貝克公司 作爲pde1抑制劑之咪唑並三酮
JO3627B1 (ar) * 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
AU2016289856B2 (en) 2015-07-07 2020-11-26 H. Lundbeck A/S PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
WO2017070293A1 (en) * 2015-10-20 2017-04-27 Ironwood Pharmaceuticals, Inc. Phosphodiesterase 9 inhibitor and levodopa therapy
CN105669680B (zh) * 2016-03-24 2018-02-23 南京药捷安康生物科技有限公司 吡咯并[2,1‑f][1,2,4]三嗪‑4(1H)‑酮衍生物类PDE9A抑制剂
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商H 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
EP3481398A1 (en) 2016-07-06 2019-05-15 Imara, Inc. Pde9 inhibitors for treatment of peripheral diseases
WO2018073251A1 (en) 2016-10-18 2018-04-26 H. Lundbeck A/S Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as pde1 inhibitors
JP2020500841A (ja) 2016-10-28 2020-01-16 ハー・ルンドベック・アクチエゼルスカベット イミダゾピラジノンの投与を含む併用療法
WO2018078038A1 (en) 2016-10-28 2018-05-03 H. Lundbeck A/S Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders
HRP20240146T1 (hr) * 2017-05-26 2024-04-12 Cardurion Pharmaceuticals, Inc. Postupci dobivanja i upotrebe inhibitora pde9
SI3801526T1 (sl) 2018-05-25 2024-05-31 Cardurion Pharmaceuticals, Inc. Monohidratne in kristalinične oblike 6-((3s, 4s)-4-metil-1-(pirimidin-2-ilmetil)pirolidin-3-il)-3-tetrahidropiran-4- il-7h-imidazo (1.5 - a) pirazin-8-ona
US20220041667A1 (en) * 2018-11-14 2022-02-10 The Board Of Trustees Of The Leland Stanford Junior University Targeting of makap-pde4d3 complexes in neurodegenerative disease
KR20200068996A (ko) * 2018-12-06 2020-06-16 한국화학연구원 Pde9a 저해 활성을 가지는 화합물 및 이들의 의약 용도
EP4049661A4 (en) * 2019-10-21 2023-11-08 SK Biopharmaceuticals Co., Ltd. USE OF AN IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE COMPOUND TO PREVENT, RELIEF OR TREAT DEVELOPMENTAL DISABILITIES
CN112724079A (zh) * 2021-02-04 2021-04-30 康化(上海)新药研发有限公司 一种6-甲氧基吡啶甲酸甲酯的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
ATE213246T1 (de) 1997-11-12 2002-02-15 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren
DE19750085A1 (de) * 1997-11-12 1999-05-20 Bayer Ag 2-Phenyl-substituierte Imidazotriazinone
US7087605B2 (en) 2001-06-01 2006-08-08 Bayer Aktiengesellschaft 5-Ethyl-imidazotriazinones
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
MXPA04004170A (es) * 2001-11-02 2004-09-06 Pfizer Prod Inc Tratamiento del sindrome de resitencia a la insulina y diabetes de tipo 2 con inhibidores de pde9.
DE10229778A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Neue Verwendung von Imidazotriazinonen
JP2007524596A (ja) 2003-02-28 2007-08-30 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 共結晶医薬組成物
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
WO2006127368A2 (en) 2005-05-20 2006-11-30 Lexicon Genetics Incorporated Methods for synthesizing imidazotriazinones
WO2007000655A2 (en) 2005-06-28 2007-01-04 Orchid Research Laboratories Limited Novel pyrazolopyrimidinone derivatives
AP2524A (en) * 2007-05-11 2012-12-04 Pfizer Amino-heterocyclic compounds
EP2297133B1 (en) 2008-06-25 2017-09-13 Forum Pharmaceuticals Inc. 1, 2 disubstituted heterocyclic compounds
CN103313988B (zh) 2010-09-20 2016-06-08 论坛医药有限公司 咪唑并三嗪酮化合物
SG11201403909RA (en) 2012-01-26 2014-10-30 Lundbeck & Co As H Pde9 inhibitors with imidazo triazinone backbone
WO2013142269A1 (en) 2012-03-19 2013-09-26 Envivo Pharmaceuticals, Inc. Imidazotriazinone compounds

Similar Documents

Publication Publication Date Title
JP2013540755A5 (US20040106767A1-20040603-C00005.png)
JP2013544860A5 (US20040106767A1-20040603-C00005.png)
JP2014508811A5 (US20040106767A1-20040603-C00005.png)
JP2013537203A5 (US20040106767A1-20040603-C00005.png)
HRP20171028T1 (hr) Indolski i indazolski spojevi koji aktiviraju ampk
JP2014521625A5 (US20040106767A1-20040603-C00005.png)
JP2015535277A5 (US20040106767A1-20040603-C00005.png)
JP2011519854A5 (US20040106767A1-20040603-C00005.png)
JP2008510770A5 (US20040106767A1-20040603-C00005.png)
JP2012092103A5 (US20040106767A1-20040603-C00005.png)
JP2017509689A5 (US20040106767A1-20040603-C00005.png)
JP2014520767A5 (US20040106767A1-20040603-C00005.png)
JP2008501000A5 (US20040106767A1-20040603-C00005.png)
JP2015537008A5 (US20040106767A1-20040603-C00005.png)
NZ705881A (en) Heteroaryl inhibitors of pde4
JP2015512931A5 (US20040106767A1-20040603-C00005.png)
JP2014526533A5 (US20040106767A1-20040603-C00005.png)
JP2012515776A5 (US20040106767A1-20040603-C00005.png)
JP2013540713A5 (US20040106767A1-20040603-C00005.png)
JP2011517453A5 (US20040106767A1-20040603-C00005.png)
RU2013118362A (ru) Соединения имидазотриазинона
JP2014526435A5 (US20040106767A1-20040603-C00005.png)
JP2014506907A5 (US20040106767A1-20040603-C00005.png)
JP2009501745A5 (US20040106767A1-20040603-C00005.png)
JP2019531279A5 (US20040106767A1-20040603-C00005.png)